newsfilter
← Latest News
Business Wire·

Virios Therapeutics, Inc. Announces Pricing of Public Offering

Virios Therapeutics, Inc. (Nasdaq: VIRI), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia, announced today the pricing of its underwritt